all - Opinion Summaries
Page 84 of 88
Showing Result 831 - 840 of 874
| Description | Date | Docket # |
|---|---|---|
FOREST LABS., INC. v. ABBOTT LABS.United States Federal Circuit
Attorney's Fees, Civil Procedure, Drugs & Biotech, Intellectual Property, PatentAward of attorneys' fees is reversed where the district court erred in finding this case to be "exceptional" under 35 U.S.C. section 285 based on... |
08/07/2003 | 03-1067 |
BROUDO v. DURA PHARMS., INC.United States Ninth Circuit
Drugs & Biotech, Securities LawA complaint satisfied the loss causation element of a Section 10(b) violation of the Securities and Exchange Act of 1934 with respect to a device for... |
08/05/2003 | 01-57136 |
SCHERING CORP. v. GENEVA PHARMS., INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentBecause the district court correctly found that plaintiff's patent for the antihistamine loratadine inherently anticipates two claims of a patent that... |
08/01/2003 | 02-1540, 03-1021 |
MCNEIL-PPC, INC. v. L. PERRIGO CO.United States Federal Circuit
Attorney's Fees, Drugs & Biotech, Intellectual Property, PatentThough the district court correctly determined that asserted claims of plaintiff's patents directed to a method for treating gastrointestinal distress... |
08/01/2003 | 02-1516 |
IN RE VITAMIN CASESCalifornia Court of Appeal
Antitrust & Trade Regulation, Attorney's Fees, Drugs & BiotechIn an antitrust class action lawsuit brought on behalf of direct purchasers of vitamins, an award of attorney fees and costs must be reversed and... |
07/24/2003 | A098354 |
TORPHARM INC. v. RANBAXY PHARMS., INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentThe grant of summary judgment invalidating plaintiff's patent based on obviousness is reversed because, despite plaintiff's assertion of improved Form... |
07/23/2003 | 02-1590 |
US v. ST. LOUIS UNIV.United States Fourth Circuit
Drugs & Biotech, Government Law, Injury & Tort Law, Product LiabilityBecause there is no evidence that the government's regulatory violations proximately caused victim's injury, defendant has failed to show that it is... |
07/16/2003 | 02-1351 |
AMERICAN CYANAMID CO. v. ST. LOUIS UNIV.United States Fourth Circuit
Drugs & Biotech, Injury & Tort Law, Product LiabilityUnder Missouri law, because defendant has simply failed to present any competent evidence showing that the defect in a vaccine (excessive... |
07/16/2003 | 02-1235 |
ABBOTT LABS v. SYNTRON BIORESEARCH, INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentJudgment of non-infringement is reversed as to two claims in a patent generally directed to devices and methods for performing chemical analysis. |
07/10/2003 | 02-1203, -1257 |
CASTILLO v. E.I. DU PONT DE NEMOURS & CO., INC.Supreme Court of Florida
Drugs & Biotech, Evidence, Injury & Tort Law, Product LiabilityExpert scientific testimony, offered at trial in a product liability and negligence claim against manufacturers of an agricultural fungicide, was... |
07/10/2003 | SC00-490 |
Results 831 to 840 of 874